2012
DOI: 10.1016/j.brainres.2012.05.020
|View full text |Cite
|
Sign up to set email alerts
|

Involvement of CX3CR1 in bone cancer pain through the activation of microglia p38 MAPK pathway in the spinal cord

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
36
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 60 publications
(40 citation statements)
references
References 39 publications
4
36
0
Order By: Relevance
“…A rat model of bone cancer pain was established as described previously (Hu et al, 2012b;Wang et al, 2011). In brief, under anesthesia with 4% Chloral Hydrate Solution (400 mg/kg, i.p.…”
Section: Bone Cancer Pain Modelmentioning
confidence: 99%
See 1 more Smart Citation
“…A rat model of bone cancer pain was established as described previously (Hu et al, 2012b;Wang et al, 2011). In brief, under anesthesia with 4% Chloral Hydrate Solution (400 mg/kg, i.p.…”
Section: Bone Cancer Pain Modelmentioning
confidence: 99%
“…L4-5 spinal cords segments were post fixed in the same fixative for 6 h at 4 1C, and then placed in a 20% sucrose solution overnight at 4 1C. Immunofluorescence was performed on 6 μm thick L4-5 transverse spinal section sand processed as previously described (Hu et al, 2012b). Both cell slides and tissue sections were incubated with primary antibodies for rabbit anti-rat p-Akt (1:100) or mouse anti-rat OX-42 (1:100) overnight at 4 1C.…”
Section: Immunofluorescencementioning
confidence: 99%
“…They were reported to contribute to the development and/or maintenance of bone cancer pain [18][19][20], neuropathic pain [21,22], and Rao Sun and Zhibin Zhao contributed equally to this work. postoperative pain [23][24][25].…”
Section: Introductionmentioning
confidence: 98%
“…Subsequently, this work demonstrated that the crosstalk between PI3K/Akt and Raf/MEK/ERK signaling pathway was the important mechanism underlying the contribution of CXCR3 activation to the development of BCP, which was proved by the results that the PI3K or MEK inhibitor could alleviate the activation of both Akt and ERK1/2 respectively. Their experiments provide new evidence to support that CXCR3 participates in central sensitization in BCP condition, like some other chemokines and their receptors (Hu et al, 2012a;Hu et al, 2012b;Liou et al, 2012;Yin et al, 2010). The exploration for the underlying mechanism of CXCR3 activation reveals the complexity of the BCP mechanism.…”
Section: Introductionmentioning
confidence: 91%